Larimar Therapeutics Results Presentation Deck
November 2022, 15 slides
  1. Larimar Therapeutics
  2. Related Decks
  3. Results Presentation Decks
safety and of single and day multiple dose administration of a replacement therapy for ataxia nancy do galas | Larimar Therapeutics
disclosures and | Larimar Therapeutics
background replacement therapy a | Larimar Therapeutics
study objective to evaluate the safety tolerability and profile of a single ascending dose and multiple ascending doses of in patients aged years with ataxia | Larimar Therapeutics
participant eligibility | Larimar Therapeutics
study design | Larimar Therapeutics
assessments | Larimar Therapeutics
participants in the sad study | Larimar Therapeutics
safety in the sad study | Larimar Therapeutics
in the sad study | Larimar Therapeutics
participants in the mad study | Larimar Therapeutics
safety in the mad study | Larimar Therapeutics
in the mad study | Larimar Therapeutics
in the mad study | Larimar Therapeutics
conclusions safety outlook | Larimar Therapeutics
See More
Larimar Therapeutics
Results Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Plasma
Recent decks by Larimar Therapeutics
Investor Presentation
November 2023
Investor Presentation
October 2022
See all presentations by Larimar Therapeutics (3 decks)
Related decks
Minerva
IPO
October 2021
Kymera
Investor Presentation
June 2023
Kymera
Investor Presentation
August 2023
NeuroBo Pharmaceuticals
Investor Presentation
December 2023
Aeglea BioTherapeutics
Investor Presentation
August 2020
Kymera
Investor Presentation
November 2023
Aeglea BioTherapeutics
Results
May 2020
Aeglea BioTherapeutics
Investor Presentation
May 2023
Recent decks by Larimar Therapeutics
See all presentations (3 decks)
Investor Presentation
November 2023
Investor Presentation
October 2022
Minerva
IPO
October 2021
Kymera
Investor Presentation
June 2023
Kymera
Investor Presentation
August 2023
NeuroBo Pharmaceuticals
Investor Presentation
December 2023
Aeglea BioTherapeutics
Investor Presentation
August 2020
Kymera
Investor Presentation
November 2023
Aeglea BioTherapeutics
Results
May 2020
Aeglea BioTherapeutics
Investor Presentation
May 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights